Cacua Sanchez MT, Buenahora G, & Carrillo Bravo CA. (2024). Effectiveness of the Use of the Human Recombinant Epidermal Growth Factor in the Subsidized Regime vs The Contributive Regime in Patients with Venous Ulcers in Bogotá. Dove Medical Press.
Chicago Style (17th ed.) CitationCacua Sanchez MT, Buenahora G, and Carrillo Bravo CA. Effectiveness of the Use of the Human Recombinant Epidermal Growth Factor in the Subsidized Regime Vs The Contributive Regime in Patients with Venous Ulcers in Bogotá. Dove Medical Press, 2024.
MLA (9th ed.) CitationCacua Sanchez MT, et al. Effectiveness of the Use of the Human Recombinant Epidermal Growth Factor in the Subsidized Regime Vs The Contributive Regime in Patients with Venous Ulcers in Bogotá. Dove Medical Press, 2024.
Warning: These citations may not always be 100% accurate.